Literature DB >> 26552743

Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men.

M Laclaustra1, Y Hurtado-Roca2, M Sendin2, M Leon3, M Ledesma3, E Andres4, A Fernandez-Ortiz2, E Guallar5, J M Ordovas2, J A Casasnovas3.   

Abstract

BACKGROUND AND AIMS: Subclinical thyroid conditions, defined by normal thyroxin (T4) but abnormal thyroid-stimulating hormone (TSH) levels, may be associated with cardiovascular and metabolic risk. More recently, TSH levels within the normal range have been suggested to be associated with metabolic syndrome and cardiovascular risk. This work studies the linearity of the relationship between metabolic syndrome and TSH across the euthyroid range. METHODS AND
RESULTS: We studied 3533 male participants of the Aragon Workers' Health Study (AWHS) with normal TSH and free T4 levels, across quintiles of these variables, after adjusting for age, alcohol intake, and smoking. Compared with the lowest TSH quintile, the odds ratios for metabolic syndrome at the higher quintiles, which indicate lower thyroid function, were 1.34 (1.04, 1.73), 1.56 (1.21, 2.01), 1.57 (1.22, 2.03), and 1.71 (1.32, 2.21). The lowest free T4 quintile also showed an odds ratio of 1.49 (1.16, 1.90) with respect to the highest quintile. In addition, spline models showed departures from linearity: the risk of metabolic syndrome mostly increases at TSH values below the median (sample half-closest to subclinical hyperthyroidism). Interestingly, glucose also increases with TSH primarily below the median TSH, diastolic blood pressure shows similar changes across the entire TSH range, whereas body mass index, triglycerides, and high-density lipoprotein (HDL)-cholesterol change only at the highest normal TSH values, which are associated with lower free T4 concentration.
CONCLUSIONS: TSH and free T4 within the normal range are associated with the metabolic syndrome. The sample half-below the TSH median (with probably higher functional thyroid status) exhibited better metabolic and cardiovascular profiles.
Copyright © 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. All rights reserved.

Entities:  

Keywords:  Cardiovascular risk factors; Male; Metabolic syndrome; TSH; Thyroid

Mesh:

Substances:

Year:  2015        PMID: 26552743     DOI: 10.1016/j.numecd.2015.09.007

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  9 in total

1.  In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.

Authors:  Elisabetta Morini; Antonino Catalano; Antonino Lasco; Nunziata Morabito; Salvatore Benvenga
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

Review 2.  Dependence of Seasonal Dynamics in Healthy People's Circulating Lipids and Carbohydrates on Regional Climate: Meta-Analysis.

Authors:  N V Kuzmenko; B F Shchegolev
Journal:  Indian J Clin Biochem       Date:  2022-08-05

3.  Thyroid function and metabolic syndrome in the population-based LifeLines cohort study.

Authors:  Bruce H R Wolffenbuttel; Hanneke J C M Wouters; Sandra N Slagter; Robert P van Waateringe; Anneke C Muller Kobold; Jana V van Vliet-Ostaptchouk; Thera P Links; Melanie M van der Klauw
Journal:  BMC Endocr Disord       Date:  2017-10-16       Impact factor: 2.763

4.  A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of l-thyroxine, may have metabolic and cardiovascular consequences.

Authors:  Salvatore Benvenga; Rachele Pantano; Giovanna Saraceno; Luigi Lipari; Antonio Alibrando; Santi Inferrera; Giuseppe Pantano; Giuseppe Simone; Sebastiano Tamà; Riccardo Scoglio; Maria Giovanna Ursino; Carmen Simone; Antonino Catalano; Umberto Alecci
Journal:  J Clin Transl Endocrinol       Date:  2019-04-10

5.  The prevalence and related factors of metabolic syndrome in outpatients with first-episode drug-naive major depression comorbid with anxiety.

Authors:  Yinghua Zhong; Manji Hu; Qiang Wang; Zhendong Yang; Na Zhu; Fei Wang; Xiyan Zhang; Chengfang Zhang; Jie Min; Hao Wang; Fazhan Chen; Xudong Zhao; Xiangyang Zhang
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

6.  Lower normal free thyroxine is associated with a higher risk of metabolic syndrome: a retrospective cohort on Chinese population.

Authors:  Xi Ding; Chun-Ying Zhu; Rui Li; Li-Ping Wu; Yue Wang; Shi-Qian Hu; Yi-Ming Liu; Feng-Yi Zhao; Yang Zhao; Meng Zhang; Ming-Qian He; Zi-Yi Chen; Bing-Yin Shi
Journal:  BMC Endocr Disord       Date:  2021-03-04       Impact factor: 2.763

7.  Circulating concentrations of free triiodothyronine are associated with central adiposity and cardiometabolic risk factors in young euthyroid adults.

Authors:  Elisa Merchan-Ramirez; Guillermo Sanchez-Delgado; Cristina Arrizabalaga-Arriazu; Francisco M Acosta; Maria Jose Arias-Tellez; Manuel Muñoz-Torres; Jose V Garcia-Lario; Jose M Llamas-Elvira; Jonatan R Ruiz
Journal:  J Physiol Biochem       Date:  2022-04-06       Impact factor: 5.080

8.  BMI Modulates the Effect of Thyroid Hormone on Lipid Profile in Euthyroid Adults.

Authors:  Yanqiu Wang; Qinglei Yin; Min Xu; Qicheng Ni; Weiqing Wang; Qidi Wang
Journal:  Int J Endocrinol       Date:  2017-08-13       Impact factor: 3.257

9.  High-normal thyroid-stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women.

Authors:  Servet Altay; Altan Onat; Günay Can; Eyyup Tusun; Barış Şimşek; Adnan Kaya
Journal:  Arch Med Sci       Date:  2016-10-26       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.